


Healthcare Industry NewsFeed
HSMN NewsFeed - 30 Aug 2019
Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering
Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering
HSMN NewsFeed - 30 Aug 2019
Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation
Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation
HSMN NewsFeed - 29 Aug 2019
AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program
AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program
HSMN NewsFeed - 28 Aug 2019
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
HSMN NewsFeed - 27 Aug 2019
EBR Systems Closes $30M in New Funding, John McCutcheon Joins Company as President and CEO
EBR Systems Closes $30M in New Funding, John McCutcheon Joins Company as President and CEO
HSMN NewsFeed - 26 Aug 2019
FDA Clears Biobeat's Wearable Watch and Patch for Non-invasive Cuffless Monitoring of Blood Pressure
FDA Clears Biobeat's Wearable Watch and Patch for Non-invasive Cuffless Monitoring of Blood Pressure
HSMN NewsFeed - 26 Aug 2019
Priya Chaturvedi, Ph.D., Appointed Vice President of Global Clinical Quality Assurance at Eisai Inc.
Priya Chaturvedi, Ph.D., Appointed Vice President of Global Clinical Quality Assurance at Eisai Inc.
HSMN NewsFeed - 22 Aug 2019
Drawbridge Health Receives FDA 510(k) Clearance for OneDraw(TM) A1C Test System
Drawbridge Health Receives FDA 510(k) Clearance for OneDraw(TM) A1C Test System
HSMN NewsFeed - 21 Aug 2019
Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal(R) Nasal Spray
Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal(R) Nasal Spray
HSMN NewsFeed - 20 Aug 2019
Vyaire Medical Receives FDA Clearance of New Pulmonary Function Testing Technology
Vyaire Medical Receives FDA Clearance of New Pulmonary Function Testing Technology
HSMN NewsFeed - 19 Aug 2019
Vanda Pharmaceuticals FDA Update for HETLIOZ(R) in the Treatment of Jet Lag Disorder
Vanda Pharmaceuticals FDA Update for HETLIOZ(R) in the Treatment of Jet Lag Disorder
